July 2018

Earle A. Chiles Research Institute, a division of Providence Cancer Institute in the Robert W. Franz Cancer Center, is currently conducting more than 140 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches.

Cellular therapy studies open for lymphoma, melanoma, lung, head and neck cancers

Providence Cancer Institute is one of the few specialized centers in the world offering clinical trials of adoptive T-cell immunotherapy, a treatment approach so promising that the American Society of Clinical Oncology (ASCO) named it the 2018 Advance of the Year . Open studies include:  CAR T-cell therapy for mantle cell lymphoma TIL therapy for non-small cell lung cancer TIL therapy for head and neck cancer Opening in late July: CAR T-cell therapy for B-cell non-Hodgkin lymphoma Read More About These Studies

All current open studies:

Brain Cancer Breast Cancer Gastrointestinal Cancers  Genitourinary Cancers Gynecologic Cancers

Head and Neck Cancers Hematologic Cancers Lung Cancer Melanoma Phase 1 Trials

Find additional studies for many types of cancer in Multiple Tumor Types .

New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.

Refer A Patient

Email Our Team

See All Open Studies

Earle A. Chiles Research Institute

Sign up to receive this newsletter

‌ ‌ ‌